From: Effects of EpCAM overexpression on human breast cancer cell lines
 | Expression of | |||||||
---|---|---|---|---|---|---|---|---|
 | TBP | SRFP1 | TCF7L2 | ITF-2 | ||||
n = 3 | Ct ± SD | CV[%] | Ct ± SD | CV[%] | Ct ± SD | CV[%] | Ct ± SD | CV[%] |
MDA-MB-231 control | 22.11 ± 1.90 | 4.95 | 31.42 ± 2.90 | 9.22 | 19.19 ± 1.45 | 7.54 | 23.47 ± 0.43 | 1.82 |
MDA-MB-231 EpCAM | 21.81 ± 0.10 | 0.47 | 34.37 ± 1.80 | 5.25 | 20.75 ± 0.27 | 1.33 | 36.26 ± 5.50 | 15.18 |
 | comparison EpCAM expressing versus control | |||||||
Regulation Factor | Â | Â | -11.06 | -3.64 | -1773.84 | |||
REST analysis | ||||||||
P(H1) | Â | Â | 0.000 | 0.000 | 0.000 | |||
Result | Â | Â | DOWN | DOWN | DOWN | |||
 | Expression of | |||||||
 | TBP | SRFP1 | TCF7L2 | ITF-2 | ||||
n = 4 | Ct ± SD | CV[%] | Ct ± SD | CV[%] | Ct ± SD | CV[%] | Ct ± SD | CV[%] |
Hs578T control | 23.23 ± 0.72 | 3.09 | 25.35 ± 2.07 | 8.17 | 21.28 ± 0.86 | 4.04 | 22.73 ± 1.81 | 7.96 |
Hs578T EpCAM | 22.54 ± 0.18 | 0.81 | 28.50 ± 3.39 | 11.91 | 20.76 ± 0.56 | 2.71 | 23.42 ± 0.54 | 2.30 |
 | comparison EpCAM expressing versus control | |||||||
Regulation Factor | Â | Â | -35.82 | -0.73 | -3.55 | |||
REST analysis | ||||||||
P(H1) | Â | Â | 0.048 | 0.658 | 0.128 | |||
Result | Â | Â | DOWN | not different to control | not different to control |